Literature DB >> 18472196

Issues with reducing the rotavirus-associated mortality by vaccination in developing countries.

Mohammadreza Naghipour1, Toyoko Nakagomi, Osamu Nakagomi.   

Abstract

More than 65% of the global rotavirus deaths were estimated to occur in 11 countries in Asia and Africa, claiming 345,000 children less than 5 years of age in 2004. While efficacious rotavirus vaccines are at hand, inequity in health delivery system within and between these countries was found to be the major hurdle against achieving the goal of rotavirus vaccine. When the coverage of currently used vaccines was applied to a rotavirus vaccine, a maximum of 202,550 deaths would be averted. Even if the coverage reached 80%, there would remain 96,841 children dying because of rotavirus diarrhea in these 11 countries. Studies are therefore encouraged to develop comprehensive strategies to resolve inequity in health delivery system enabling the increase in the immunization coverage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18472196     DOI: 10.1016/j.vaccine.2008.04.004

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Impact of introducing the pneumococcal and rotavirus vaccines into the routine immunization program in Niger.

Authors:  Bruce Y Lee; Tina-Marie Assi; Jayant Rajgopal; Bryan A Norman; Sheng-I Chen; Shawn T Brown; Rachel B Slayton; Souleymane Kone; Hailu Kenea; Joel S Welling; Diana L Connor; Angela R Wateska; Anirban Jana; Ann E Wiringa; Willem G Van Panhuis; Donald S Burke
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

Review 2.  Rotavirus infections and vaccines: burden of illness and potential impact of vaccination.

Authors:  Keith Grimwood; Stephen B Lambert; Richard J Milne
Journal:  Paediatr Drugs       Date:  2010-08-01       Impact factor: 3.022

3.  Molecular characterization of rotavirus strains detected during a clinical trial of a human rotavirus vaccine in Blantyre, Malawi.

Authors:  Toyoko Nakagomi; Osamu Nakagomi; Winifred Dove; Yen Hai Doan; Desiree Witte; Bagrey Ngwira; Stacy Todd; A Duncan Steele; Kathleen M Neuzil; Nigel A Cunliffe
Journal:  Vaccine       Date:  2012-04-27       Impact factor: 3.641

4.  Innate immune responses to human rotavirus in the neonatal gnotobiotic piglet disease model.

Authors:  Ana M González; Marli S P Azevedo; Kwonil Jung; Anastasia Vlasova; Wei Zhang; Linda J Saif
Journal:  Immunology       Date:  2010-10       Impact factor: 7.397

5.  Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: randomized, double-blind, placebo-controlled Phase I studies.

Authors:  Rong-Cheng Li; Yan-Ping Li; Zhao-Jun Mo; Dong Luo; Teng Huang; Ji-Lian Kong; Lao-Hong Wang; Ning-Sheng Song; Aixue Liu; Helen Zhang; Xueyan Liao; Naveen Karkada; Htay Htay Han
Journal:  Hum Vaccin Immunother       Date:  2013-06-04       Impact factor: 3.452

Review 6.  Management of Diarrhoeal Dehydration in Childhood: A Review for Clinicians in Developing Countries.

Authors:  Emmanuel Ademola Anigilaje
Journal:  Front Pediatr       Date:  2018-02-23       Impact factor: 3.418

7.  Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis.

Authors:  Johnie Rose; Rachael L Hawthorn; Brook Watts; Mendel E Singer
Journal:  BMJ       Date:  2009-09-25

8.  G8 rotaviruses with conserved genotype constellations detected in Malawi over 10 years (1997-2007) display frequent gene reassortment among strains co-circulating in humans.

Authors:  Toyoko Nakagomi; Yen Hai Doan; Winifred Dove; Bagrey Ngwira; Miren Iturriza-Gómara; Osamu Nakagomi; Nigel A Cunliffe
Journal:  J Gen Virol       Date:  2013-02-13       Impact factor: 3.891

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.